MX2009001037A - Preparacion liquida acuosa que contiene compuesto de amida. - Google Patents

Preparacion liquida acuosa que contiene compuesto de amida.

Info

Publication number
MX2009001037A
MX2009001037A MX2009001037A MX2009001037A MX2009001037A MX 2009001037 A MX2009001037 A MX 2009001037A MX 2009001037 A MX2009001037 A MX 2009001037A MX 2009001037 A MX2009001037 A MX 2009001037A MX 2009001037 A MX2009001037 A MX 2009001037A
Authority
MX
Mexico
Prior art keywords
aqueous liquid
liquid preparation
amide compound
preparation containing
containing amide
Prior art date
Application number
MX2009001037A
Other languages
English (en)
Inventor
Shirou Sawa
Hiroyuki Fujii
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of MX2009001037A publication Critical patent/MX2009001037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)

Abstract

Un objeto de la presente invención es promover la penetración de un compuesto que tiene una actividad inhibitoria de Rho-cinasa a una porción tópica, y proporcionar una preparación líquida acuosa capaz de mantener una concentración determinada de fármaco aun cuando se reduce la frecuencia de administración. La presente invención soluciona el problema mencionado anteriormente por una preparación líquida acuosa que contiene un compuesto representado por la siguiente fórmula (I) (ver fórmula I) en donde cada símbolo es como se define en la especificación, un isómero del mismo y/o una sal de adición de ácido farmacéuticamente aceptable del mismo, y un reactivo de apareamiento iónico o un polímero soluble en agua.
MX2009001037A 2006-07-31 2007-07-30 Preparacion liquida acuosa que contiene compuesto de amida. MX2009001037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006209102 2006-07-31
PCT/JP2007/064916 WO2008016016A1 (fr) 2006-07-31 2007-07-30 Préparation liquide aqueuse contenant un amide

Publications (1)

Publication Number Publication Date
MX2009001037A true MX2009001037A (es) 2009-05-15

Family

ID=38997192

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001037A MX2009001037A (es) 2006-07-31 2007-07-30 Preparacion liquida acuosa que contiene compuesto de amida.

Country Status (11)

Country Link
US (1) US20090247552A1 (es)
EP (1) EP2050449A4 (es)
JP (1) JPWO2008016016A1 (es)
KR (1) KR20090057223A (es)
CN (1) CN101495117B (es)
AU (1) AU2007279766A1 (es)
BR (1) BRPI0714782A2 (es)
CA (1) CA2659687A1 (es)
MX (1) MX2009001037A (es)
RU (1) RU2476219C2 (es)
WO (1) WO2008016016A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2580108T3 (es) 2005-07-11 2016-08-19 Aerie Pharmaceuticals, Inc Compuestos de isoquinolina
CA2664335C (en) 2006-09-20 2014-12-02 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8455514B2 (en) 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2834451T3 (es) 2009-05-01 2021-06-17 Aerie Pharmaceuticals Inc Inhibidores de mecanismo doble para el tratamiento de enfermedades
WO2011080984A1 (en) * 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
KR20150056619A (ko) * 2012-09-17 2015-05-26 바인드 쎄라퓨틱스, 인크. 치료제를 포함하는 치료 나노입자 및 그의 제조 및 사용 방법
PT2895156T (pt) 2012-09-17 2019-06-28 Pfizer Processo para a preparação de nanopartículas terapêuticas
EP2976080B1 (en) 2013-03-15 2019-12-25 Aerie Pharmaceuticals, Inc. Conjugates of isoquinoline compounds and prostaglandins
DK3046584T3 (en) 2013-09-16 2017-10-02 Astrazeneca Ab THERAPEUTIC POLYMER NANOPARTICLES AND PROCEDURES FOR PREPARING AND USING THEREOF
SI3116547T1 (sl) 2014-03-14 2019-08-30 Pfizer, Inc. Terapevtski nanodelci, ki obsegajo terapevtsko stredstvo, in postopek izdelave ter uporabe le-teh
EP3376870B1 (en) 2015-11-17 2021-08-11 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
JP2020515583A (ja) 2017-03-31 2020-05-28 アエリエ ファーマシューティカルズ インコーポレイテッド アリールシクロプロピル−アミノ−イソキノリニルアミド化合物
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138177A (en) * 1976-04-16 1979-02-06 Valer Andrew F Van Safety vehicle power distribution system
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
JPH0680054B2 (ja) 1985-06-19 1994-10-12 吉富製薬株式会社 ピペリジン誘導体
JP2563336B2 (ja) 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
JP2770497B2 (ja) 1988-11-24 1998-07-02 吉富製薬株式会社 トランス―４―アミノ（アルキル）―１―ピリジルカルバモイルシクロヘキサン化合物およびその医薬用途
JP3275389B2 (ja) 1991-09-06 2002-04-15 三菱ウェルファーマ株式会社 ４−アミノ（アルキル）シクロヘキサン−１−カルボン酸アミド化合物
JP3265695B2 (ja) 1992-05-12 2002-03-11 三菱ウェルファーマ株式会社 ４−置換アミノ（アルキル）シクロヘキサン−１−カルボン酸アミド化合物
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
ATE359822T1 (de) * 1996-08-12 2007-05-15 Mitsubishi Pharma Corp Medikamente enthaltend rho-kinase inhibitoren
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US6335335B2 (en) * 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
DE69839152T2 (de) * 1997-11-05 2009-02-26 Senju Pharmaceutical Co., Ltd. Augentropfen mit verlängerter freisetzung
NZ506921A (en) 1998-04-07 2002-02-01 Alcon Lab Inc Gelling ophthalmic compositions containing xanthan gum
CA2307285C (en) * 1998-08-17 2009-03-31 Senju Pharmaceutical Co., Ltd. Agent for prophylaxis and treatment of glaucoma
CA2443918C (en) * 2001-04-11 2012-06-05 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
DK1392292T3 (da) * 2001-06-01 2006-05-29 Alcon Inc Pyranoindazoler og deres anvendelse til behandling af glaukom
US7972612B2 (en) * 2002-11-18 2011-07-05 Santen Pharmaceutical Co., Ltd. Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
EP1752456B1 (en) * 2004-06-03 2015-08-26 Senju Pharmaceutical Co., Ltd. Corneal perception recovery drug containing amide compound
US7669262B2 (en) * 2004-11-10 2010-03-02 Allen Medical Systems, Inc. Accessory frame for spinal surgery
JP4818712B2 (ja) 2004-12-28 2011-11-16 大日本印刷株式会社 表示素子用黒色樹脂組成物、及び表示素子用部材

Also Published As

Publication number Publication date
CN101495117B (zh) 2012-08-15
BRPI0714782A2 (pt) 2013-07-16
AU2007279766A1 (en) 2008-02-07
JPWO2008016016A1 (ja) 2009-12-24
CN101495117A (zh) 2009-07-29
RU2009107191A (ru) 2010-09-10
EP2050449A4 (en) 2010-10-06
CA2659687A1 (en) 2008-02-07
WO2008016016A1 (fr) 2008-02-07
KR20090057223A (ko) 2009-06-04
EP2050449A1 (en) 2009-04-22
US20090247552A1 (en) 2009-10-01
RU2476219C2 (ru) 2013-02-27

Similar Documents

Publication Publication Date Title
MX2009001037A (es) Preparacion liquida acuosa que contiene compuesto de amida.
GEP20125425B (en) Biaryl ether urea compounds
EA201300200A1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
TNSN06411A1 (en) Pyrimidine urea derivatives as kinase inhibitors
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2012007869A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
MX394360B (es) Inhibidores de jak2 y alk2 y metodos para su uso.
MX2013004733A (es) Inhibidores de n1/n2-lactama acetil-coa carboxilasa.
MX336191B (es) Derivados de carbamato de hexafluoroisopropilo, su preparacion y su uso en terapeutica.
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201071409A1 (ru) Новые соли (4-{[(5-{[(3-хлорфенил)метил]окси}-2-метилфенил)карбонил]амино}-3-метилфенил)уксусной кислоты
JO2852B1 (en) Anti-cancer compounds and pharmaceutical compositions
WO2007090749A3 (en) Benzamide and heteroarene derivatives as cetp inhibitors
TW200738653A (en) Anthranilamide/2-amino-heteroarene carboxamide derivatives
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
EA201170273A1 (ru) Твердая фармацевтическая композиция
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
UA112541C2 (uk) Застосування гідрохлориду амброксолу для лікування гострого фарингіту
DK2391352T3 (da) Farmaceutiske former til frigivelse af aktive forbindelser
FR2937867B1 (fr) Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
BRPI0708098B8 (pt) derivados de 4-benzoilaminofenil)-6,7-dimetóxi-2-metilaminoquinazolina, composição farmacêutica e agente antiprurítico

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: SENJU PHARMACEUTICAL CO., LTD.

FA Abandonment or withdrawal